flt3 mutations for targeted therapy in aml
Published 5 years ago • 157 plays • Length 3:14Download video MP4
Download video MP3
Similar videos
-
0:49
treatment avenues for patients with r/r flt3-mutated aml: optimizing flt3 inhibitors
-
1:06
investigating the molecular and clinical features of flt3-jmd mutations in aml
-
1:32
novel treatment combinations for flt3-mutated aml
-
5:24
safety by treatment phase and age when treating flt3-itd-mutated aml with quizartinib and chemo
-
1:33
the current guidelines and therapies for tp53-mutated mds and aml
-
1:57
insights into the treatment of patients with flt3-mutated aml & the role of maintenance therapy
-
1:52
the management of r/r flt3-mutated aml
-
2:15
treatment strategies for patients with aml who possess a flt3 mutation
-
0:51
unmet needs in front-line therapy for patients with flt3-mutated aml
-
2:29
flt3 inhibitors as maintenance therapy in aml
-
1:21
gemtuzumab-based induction chemotherapy with midostaurin in flt3-mutated aml
-
1:24
mechanisms of resistance to flt3 inhibitors in aml and strategies to overcome this
-
1:44
new targets to treat acute myeloid leukemia (aml) with flt3 mutations
-
2:43
gemtuzumab ozogamicin in frontline aml therapy
-
6:47
the 2021 treatment algorithm for flt3-mutated aml
-
1:30
a phase i trial investigating a novel oral flt3 inhibitor, bmf-500, in flt3-mutant aml
-
1:40
sf3b1 as therapeutic target in flt3/itd positive aml
-
4:47
the use of flt3 inhibitors in aml
-
1:12
the value of flt3 inhibitors in aml and focus for future trial designs